Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-06
2010-06-01
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S412000, C548S250000, C548S516000
Reexamination Certificate
active
07728022
ABSTRACT:
Compounds of formula I:are disclosed. The compounds are useful in treating or preventing diseases associated with deposition of Aβ in the brain.
REFERENCES:
patent: 806 805 (1974-02-01), None
patent: 1 193 260 (2002-04-01), None
patent: WO 99/25340 (1999-05-01), None
patent: WO 01/78721 (2001-10-01), None
patent: WO 02/48150 (2002-06-01), None
patent: WO 2004/064771 (2004-08-01), None
patent: WO 2005/013985 (2005-02-01), None
Bettati Michela
Churcher Ian
Doughty Victoria Alexandra
Harrison Timothy
Nizi Emmanuela
Devlin Gerard
Fierro Alicia L
Merck Sharp & Dohme Ltd.
Shameem Golam M. M.
Yuro Raynard
LandOfFree
(4, 5, 6, 7-tetrahydro-1-H-indol-7-yl) acetic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (4, 5, 6, 7-tetrahydro-1-H-indol-7-yl) acetic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (4, 5, 6, 7-tetrahydro-1-H-indol-7-yl) acetic acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4234864